Corvus Pharmaceuticals (CRVS) Earnings Analysis
Corvus Pharmaceuticals (CRVS) next reports earnings on 2026-08-06, consensus EPS -0.17 USD. Last quarter (2026-05-07) it missed with EPS -0.15 USD vs -0.14 USD est (-7.1%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -25.44.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CRVS next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.17 USD |
| Revenue estimate | n/a |
CRVS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.15 USD | -0.14 USD | -7.1% | Miss |
| 2026-03-12 | -0.15 USD | -0.14 USD | -7.1% | Miss |
| 2025-08-07 | -0.1 USD | -0.13 USD | +23.1% | Beat |
| 2025-05-08 | -0.13 USD | -0.13 USD | 0% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
CRVS valuation and analyst view
| Trailing P/E | -25.44 |
|---|---|
| Trailing EPS | -0.49077 USD |
| Price / book | 5.23 |
| Dividend yield | 0.00% |
| Market cap | 1.17B |
| Analyst consensus | Buy (12 buy / 1 hold / 0 sell) |
| Avg price target | 27.56 USD |
Related research pages
Frequently asked questions
When is Corvus Pharmaceuticals (CRVS)'s next earnings date?
Corvus Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.17 USD.
Did CRVS beat earnings last quarter?
In its 2026-05-07 report, CRVS posted EPS of -0.15 USD versus a -0.14 USD estimate — a miss of 7.1%.
What is CRVS's earnings track record?
Over the last 4 reported quarters with consensus data, CRVS beat estimates 2 times (50%).
What is CRVS's current P/E ratio and EPS?
CRVS trades at a trailing P/E of -25.44 on trailing EPS of -0.4907733978950879 USD.
What do analysts rate CRVS?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 27.56 USD.